 |
30 Diseases |  |
0 Trials |
|
0 Trials |  |
1 News |  |
- MK0249 / Merck (MSD)
Enrollment change: A Study to Evaluate the Effects of MK-0249 and an Alzheimer's Disease Medication on Cognitive Function in Adults With Alzheimer's Disease (MK-0249-023) (clinicaltrials.gov) - Dec 24, 2014
P1, N=4, Terminated, Sponsor: Merck Sharp & Dohme Corp.
N=44 --> 4